Status:
RECRUITING
Changes in Perioperative Blood Volume and Fluid Distribution in Patients Undergoing Primary Total Hip Replacement.
Lead Sponsor:
Copenhagen University Hospital, Hvidovre
Conditions:
Hip Arthroplasty Replacement
Eligibility:
All Genders
18+ years
Brief Summary
Clinical assessment of bleeding and calculation of perioperative blood loss do not provide an accurate estimate of blood volume. This makes rational fluid management difficult, which is of high import...
Eligibility Criteria
Inclusion
- Patients scheduled for an elective total hip arthoplasty (THA) in a standardized fast track setting.
- Capable of participating in CO-rebreathing measurement
- Age ≥ 18 years
- Able to speak and understand Danish
- Has provided written informed consent.
Exclusion
- Intraoperative blood loss exceeding 750 mL.
- Perioperative need for a blood transfusion.
- Confirmed or suspected coagulopathies.
- Factors that make CO-rebreathing measurement impossible.
- Known orthostatic intolerance.
- American Society of Anesthesiologists physical status (ASA) classification ≥ 4.
Key Trial Info
Start Date :
March 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT06888908
Start Date
March 1 2025
End Date
September 1 2026
Last Update
March 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hvidovre University Hospital
Copenhagen, Denmark, 2960